查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046098

解剖病理學市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、技術、應用、最終用戶、地區和競爭格局分類，2021-2031年

Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technique, By Application, By End-User By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球解剖病理學市場預計將經歷顯著成長，從 2025 年的 360.9 億美元成長到 2031 年的 572.1 億美元，複合年成長率為 7.98%。

在這一領域，透過顯微鏡檢查組織和細胞，可以了解疾病進展並輔助選擇治療方法方案。這一領域的成長主要受慢性病盛行率上升和全球人口老化的影響，這兩方面都導致對切片檢查技術的需求增加。此外，人們越來越重視早期檢測和預防性醫療保健策略，進一步推動了這一成長趨勢。例如，美國癌症協會預測，到2025年，美國將新增約200萬例癌症病例，凸顯了準確病理評估的關鍵作用。

市場概覽
預測期 2027-2031
市場規模：2025年 360.9億美元
市場規模：2031年 572.1億美元
複合年成長率：2026-2031年 7.98%
成長最快的細分市場 藥物發現與開發
最大的市場 北美洲

然而，市場擴張面臨的主要障礙是能夠滿足日益成長的診斷需求的熟練病理學家短缺。這種專家的匱乏限制了檢查室能力，導致結果報告延遲，並可能對患者的治療效果產生負面影響。因此，難以招募這些專家是屍檢病理服務在全球擴張的主要阻礙。

市場促進因素

推動解剖病理學市場擴張的主要因素是全球癌症和其他慢性疾病病例的不斷增加，這必然導致對診斷技術的需求成長。隨著複雜癌症病例的增多，檢查室必須有效處理組織檢體，同時確保高診斷準確率，這對於制定有效的治療方案至關重要。此外，對腫瘤進行準確的分期和分級分類，指南先進的治療性介入，也進一步加劇了這項需求。世界衛生組織（WHO）下屬的國際癌症研究機構（IARC）在2024年2月發布的報告顯示，2022年全球癌症患者人數約為2000萬，預計到2050年將成長77%，凸顯了這一迫切需求。

同時，人工智慧 (AI) 和數位病理解決方案的應用正在革新檢查室運作，顯著提升工作流程效率和診斷準確性。玻片數位化和機器學習演算法的應用使病理學家能夠實現常規任務的自動化，更精準地量化生物標記，並減輕因人手不足造成的工作負擔。這項技術進步正推動著產業進行大規模整合和投資，旨在提升整個醫療保健系統的數位化能力。例如，2024 年 9 月，羅氏透過整合來自八家合作夥伴的 20 多種先進 AI 演算法，擴展了其數位病理生態系統，以支持癌症診斷。同樣，2024 年 5 月，Quest Diagnostics 收購了 PathAI Diagnostics 的特定資產，這表明其正在朝著以技術驅動的服務方向發展，旨在加速 AI 在其整個病理網路中的應用。

市場挑戰

全球解剖病理市場擴張的最大障礙是合格病理醫師的嚴重短缺。這種短缺是診斷流程中的一個主要瓶頸，直接限制了檢查室能夠有效處理的檢體數量。隨著切片檢查和複雜疾病分析需求的不斷成長，缺乏合適的專家迫使現有員工永續工作。這種限制不可避免地導致檢測結果延遲，限制了病理服務機構擴大營運規模以滿足全球需求的能力，從而阻礙了收入成長和市場拓展。

近期行業統計數據凸顯了營運壓力之大。英國英國病理學院在2025年報告中指出，60%的顧問醫師為了應對日益成長的臨床工作量和填補人員短缺，不得不加班。這種對超負荷人員的依賴，凸顯了供需失衡的嚴重性。因此，由於專家短缺，檢查室無法充分利用不斷成長的診斷需求，這不僅阻礙了更多病例的順利處理，也限制了整個市場的發展。

市場趨勢

伴隨診斷在精準醫療中的日益普及，正從根本上重塑解剖病理市場，使其從傳統的形態學診斷轉向基於分子水平的治療選擇。隨著製藥公司加速開發標靶治療並結合特定的診斷檢測方法，病理檢查室必須實施複雜的檢測方案，才能準確識別符合這些治療條件的患者。這一趨勢得益於強大的精準醫療研發管線，其中每張處方都需要檢驗的生物標記。 2024年2月，個人化醫療聯盟報告稱，FDA在2023年核准了16種針對罕見疾病的新型個人化治療方法。這代表著顯著的成長，凸顯了臨床實踐中對整合診斷和治療方案的日益依賴。

同時，分子病理學和解剖病理學診斷的融合正將全面的基因組分析整合到標準的組織病理學工作流程中。病理檢查室正在採用次世代定序平台，該平台能夠分析單次切片檢查中的數百個基因，而不僅僅是檢測單一分析物。這種方法簡化了診斷流程，並保留了寶貴的組織樣本。這種整合使病理學家能夠更全面地了解腫瘤的生物學特徵，從而快速為複雜的腫瘤病例提供可操作的見解。為了象徵這一轉變，Illumina公司於2024年8月宣布，其TruSight Oncology Comprehensive檢測已獲得FDA核准，該檢測可分析500多個基因，並將固態腫瘤患者與合適的標靶治療聯繫起來。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球解剖學和病理學市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（組織病理學、細胞病理學、外科病理學、其他）
    • 透過技術手段（特殊染色、免疫組織化學、電子顯微鏡、基因檢測等）
    • 按應用領域（疾病診斷、藥物發現、藥物開發）
    • 依最終用戶（醫院、研究機構、診斷檢驗實驗室等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美解剖病理學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲解剖病理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區解剖病理學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲解剖病理學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲解剖病理學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球解剖病理學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Quest Diagnostics Inc
  • Danaher Corporation
  • PHC Holdings Corporation
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche AG
  • Agilent Technologies Inc.
  • Cardinal Health Inc.
  • Sakura Finetek USA Inc.
  • NeoGenomics Laboratories Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17403

The global anatomic pathology market is projected for significant growth, expanding from USD 36.09 billion in 2025 to USD 57.21 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.98%. This sector involves the microscopic study of tissues and cells to understand disease progression and inform treatment choices. Growth is largely fueled by an increasing worldwide prevalence of chronic diseases and an aging population, both of which drive a higher demand for biopsy procedures. This upward trend is further bolstered by a stronger emphasis on early detection and proactive healthcare strategies. For instance, the American Cancer Society anticipates around 2 million new cancer diagnoses in the United States in 2025, underscoring the vital role of precise pathological assessment.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 36.09 Billion
Market Size 2031USD 57.21 Billion
CAGR 2026-20317.98%
Fastest Growing SegmentDrug Discovery and development
Largest MarketNorth America

A substantial obstacle to the market's expansion, however, is the scarcity of skilled pathologists available to manage the escalating diagnostic requirements. This shortage of specialized personnel limits the operational capabilities of laboratories, resulting in delayed result reporting, which can negatively affect patient outcomes. Therefore, the restricted availability of these expert professionals acts as a key impediment that could hinder the global scalability of anatomic pathology services.

Market Driver

The primary driver behind the anatomic pathology market's expansion is the escalating worldwide occurrence of cancer and other chronic diseases, which inherently increases the need for diagnostic procedures. As more complex cancer cases emerge, laboratories are under pressure to efficiently process tissue samples while ensuring high diagnostic accuracy crucial for effective treatment planning. This demand is intensified by the imperative for precise tumor staging and grading, which are essential for guiding advanced therapeutic interventions. The World Health Organization's International Agency for Research on Cancer reported in February 2024 that the global cancer burden reached approximately 20 million new cases in 2022, with a projected 77% increase by 2050, highlighting this pressing need.

Concurrently, the adoption of artificial intelligence (AI) and digital pathology solutions is revolutionizing laboratory operations, improving both workflow efficiency and diagnostic accuracy. Through the digitization of glass slides and the application of machine learning algorithms, pathologists can automate routine tasks, achieve more precise quantification of biomarkers, and alleviate the operational strain caused by workforce shortages. This technological evolution is fostering substantial industry consolidation and investment, focused on scaling digital capabilities throughout healthcare systems. For example, Roche expanded its digital pathology ecosystem in September 2024 by incorporating over 20 advanced AI algorithms from eight partners to aid cancer diagnosis. Similarly, in May 2024, Quest Diagnostics acquired specific assets from PathAI Diagnostics, signaling a broader trend toward tech-enabled services aimed at accelerating AI adoption across its pathology network.

Market Challenge

The foremost challenge impeding the expansion of the Global Anatomic Pathology Market is the severe dearth of qualified pathologists. This insufficient workforce creates a critical bottleneck within the diagnostic process, directly limiting the number of specimens laboratories can efficiently handle. With the increasing demand for biopsy procedures and intricate disease analyses, the lack of adequate specialized personnel compels current staff to work beyond their sustainable capacity. This limitation invariably causes delays in test results and curtails the capacity of pathology services to scale operations to satisfy worldwide requirements, consequently hindering revenue growth and market development initiatives.

Recent industry figures underscore the extent of this operational pressure. The Royal College of Pathologists reported in 2025 that 60% of consultants were working past their contracted hours to manage the growing clinical workload and fill staff vacancies. This dependence on an overstretched workforce emphasizes the gravity of the imbalance between supply and demand. As a result, laboratories cannot fully leverage the increasing diagnostic needs, given that the scarcity of experts impedes the seamless integration of larger caseloads and restricts overall market advancement.

Market Trends

The growing adoption of companion diagnostics for precision medicine is fundamentally reshaping the anatomic pathology market, steering it from traditional morphological diagnosis toward molecular-guided therapeutic choices. As pharmaceutical firms increasingly develop targeted therapies alongside specific diagnostic assays, pathology laboratories are required to implement sophisticated testing protocols capable of precisely identifying patients who qualify for these treatments. This trend is directly supported by the strong pipeline of precision medicines, all of which necessitate validated biomarkers for their prescription. The Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized treatments for rare diseases in 2023, signifying a notable rise and underscoring the increasing dependence on integrated diagnostic-therapeutic pairings in clinical practice.

Concurrently, the amalgamation of molecular and anatomic pathology diagnostics is prompting the incorporation of comprehensive genomic profiling into standard tissue-based workflows. Pathology laboratories are advancing beyond testing for single analytes, embracing next-generation sequencing platforms that can analyze hundreds of genes from a single biopsy. This approach streamlines the diagnostic process and preserves valuable tissue samples. Such integration allows pathologists to offer a more complete understanding of tumor biology and expedites the provision of actionable insights for intricate oncology cases. Illustrating this transition, Illumina announced in August 2024 that the FDA approved its TruSight Oncology Comprehensive test, which profiles over 500 genes to link patients with solid tumors to suitable targeted therapies.

Key Market Players

  • Quest Diagnostics Inc
  • Danaher Corporation
  • PHC Holdings Corporation
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche AG
  • Agilent Technologies Inc.
  • Cardinal Health Inc.
  • Sakura Finetek USA Inc.
  • NeoGenomics Laboratories Inc.

Report Scope

In this report, the Global Anatomic Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anatomic Pathology Market, By Type

  • Histopathology
  • Cytopathology
  • Surgical Pathology
  • Others

Anatomic Pathology Market, By Technique

  • Special Staining
  • Immunohistochemistry
  • Electron Microscopy
  • Genetic Testing
  • Others

Anatomic Pathology Market, By Application

  • Disease Diagnosis
  • Drug Discovery
  • Development

Anatomic Pathology Market, By End-User

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Anatomic Pathology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Market.

Available Customizations:

Global Anatomic Pathology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anatomic Pathology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Histopathology, Cytopathology, Surgical Pathology, Others)
    • 5.2.2. By Technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing, Others)
    • 5.2.3. By Application (Disease Diagnosis, Drug Discovery, Development)
    • 5.2.4. By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Anatomic Pathology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Anatomic Pathology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Anatomic Pathology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Anatomic Pathology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Anatomic Pathology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Anatomic Pathology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Anatomic Pathology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Anatomic Pathology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Anatomic Pathology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Anatomic Pathology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia Pacific Anatomic Pathology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Anatomic Pathology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Anatomic Pathology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Anatomic Pathology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Anatomic Pathology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Anatomic Pathology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Anatomic Pathology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Anatomic Pathology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Anatomic Pathology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Anatomic Pathology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. South America Anatomic Pathology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Anatomic Pathology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Anatomic Pathology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Anatomic Pathology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Anatomic Pathology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Quest Diagnostics Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. PHC Holdings Corporation
  • 15.4. Laboratory Corporation of America Holdings
  • 15.5. F. Hoffmann-La Roche AG
  • 15.6. Agilent Technologies Inc.
  • 15.7. Cardinal Health Inc.
  • 15.8. Sakura Finetek USA Inc.
  • 15.9. NeoGenomics Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer